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Hantavirus pulmonary syndrome (HPS),
first recognized in 1993 after a cluster of acute
respiratory distress syndrome deaths in the
southwestern United States, is now considered a
pan-American zoonosis (1,2). HPS is character-
ized by fever, myalgia, gastrointestinal symp-
toms, and headache, with subsequent character-
istic cardiopulmonary dysfunction and a 40% to
60% case-fatality rate (3). Although the etiologic
agent, Sin Nombre virus (SNV), causes clinical
symptoms that appear different from those that
Eurasian hantaviruses cause in hemorrhagic
fever with renal syndrome, SNV shares many
features with these Old World hantaviruses
(4,5), including an association with a single
primary rodent host (Peromyscus maniculatus
[deer mouse] in the case of SNV), which acts as
the natural reservoir (6).
After SNV was  identified, numerous other
New World hantaviruses were rapidly identified
throughout the Americas by reverse transcrip-
tion-polymerase chain reaction (RT-PCR) ampli-
fication of viral RNA from captured antibody-
positive rodents and, occasionally, from infected
patients (2). HPS was first identified in Chile in
1995 in the Cochamo, Los Lagos region. Genetic
sequencing of RT-PCR products from the autopsy
tissues of another patient presumptively infected
in this region in 1996 confirmed infection with
Andes virus (7), which had previously been
identified in southern Argentina as a cause of
HPS, with Oligoryzomys longicaudatus postu-
lated as the reservoir host (8). Sporadic cases
were reported in Chile until an outbreak that
included two family clusters was recognized in
the Coyhaique Health District, Aysen region, in
August 1997; a third cluster was reported in
January 1998. This outbreak prompted a joint
investigation by the National Administration of
Laboratories and Institutes of Health (Argen-
tina), Pan American Health Organization,
Centers for Disease Control and Prevention
(CDC, USA), in collaboration with the Ministry
of Health of Chile, to define the epidemiology and
ecology of the syndrome in Chile.
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An outbreak of 25 cases of Andes virus-associated hantavirus pulmonary syndrome
(HPS) was recognized in southern Chile from July 1997 through January 1998. In addition
to the HPS patients, three persons with mild hantaviral disease and one person with
asymptomatic acute infection were identified. Epidemiologic studies suggested person-to-
person transmission in two of three family clusters.  Ecologic studies showed very high
densities of several species of sigmodontine rodents in the area.688 Emerging Infectious Diseases Vol. 4, No. 4, OctoberDecember 1998
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The Investigation
Epidemiologic Surveillance and Case
Identification
National and local surveillance for HPS was
reinforced with explicit case definitions for HPS,
asymptomatic hantavirus infection, and mild
hantaviral disease. HPS was defined as an acute
febrile illness (temperature >38.3°C) character-
ized by unexplained acute respiratory distress
syndrome or bilateral interstitial pulmonary
infiltrates, with respiratory compromise requir-
ing supplemental oxygen, or an unexplained
illness resulting in death, with autopsy results
showing noncardiogenic pulmonary edema
without an identifiable specific cause of death. In
addition to a compatible clinical illness, the
following laboratory evidence of infection
was required: 1) hantavirus-specific immu-
noglobulin M (IgM) or a fourfold rise in IgG
titer, or 2) positive RT-PCR results for
hantavirus RNA, or 3) positive immunohis-
tochemical results for hantavirus antigen.
Asymptomatic hantavirus infection was
defined as laboratory evidence of acute
hantavirus infection (presence of IgM antibod-
ies) in persons with no documented concurrent
illness. Mild hantaviral disease was defined as
IgM-positive results and a febrile illness without
objective pulmonary dysfunction (i.e., hypox-
emia and radiographic abnormalities). All other
persons with isolated detectable hantavirus-
specific IgG antibodies were classified as other
seropositives.
All available clinical charts and case reports
from the Aysen region were reviewed in
conjunction with interviews of family members
from the two described clusters and survivors. A
third cluster was identified in January 1998 and
was also reviewed.
Ecologic Studies
Rodents were trapped at two principal sites
near the residence sites of the first two reported
family clusters, as well as in several areas of less
disturbed native vegetation in Lago Atravesado.
Traps were placed at each of the two case-
households, as well as at two neighboring
controls for each case-household (one within 500
m and the other 500 m to 1,000 m). Each evening,
150 to 200 live-capture traps were placed within
and around residences, outbuildings, gardens,
and woodpiles, along fence lines, and within
remnant patches of native vegetation. Traps
were checked in the early morning, and samples
of blood and organ tissues were collected
according to standardized protocols (9). For
comparison, we used similar trapping tech-
niques at additional sites near Valdivia (700 km
north of the outbreak area) and the capital city of
Santiago (1,400 km north). Rodent taxonomy is
as described by Musser and Carleton, 1993 (10).
Laboratory Testing
Human serum specimens were tested for IgG
antibodies reactive with SNV and Andes
antigens by an enzyme-linked immunosorbent
assay (ELISA) (11). Rodent whole-blood speci-
mens were similarly tested for IgG antibodies to
SNV. An IgM-capture ELISA was performed on
human sera by using inactivated Laguna Negra
virus at CDC and an IgM-capture ELISA with
recombinant Andes nucleocapsid antigen at the
National Institute for Infectious Disease, Buenos
Aires, Argentina (P. Padula, unpub. data).
Immunohistochemical analysis for hantaviral
antigens was performed by using a cross-reactive
monoclonal antibody directed against conserved
hantaviral nucleocapsid epitopes (12). Speci-
mens from HPS patients were also examined for
viral genetic materials (M and S segment) by
nested and heminested RT-PCR from either
autopsied tissues or blood clot samples (13,14).
Genetic sequencing of RT-PCR products derived
from patient samples was also performed.
The Outbreak
From October 1995 when HPS was first
recognized in Chile through June 1997, seven
additional cases were identified (Figure 1).
Between July 1, 1997, and January 22, 1998, 25
Figure 1. Temporal distribution of hantavirus
pulmonary syndrome cases, Chile, 1995-1998.689 Vol. 4, No. 4, OctoberDecember 1998 Emerging Infectious Diseases
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HPS patients and three family clusters were
identified in Chile. By RT-PCR we confirmed
that 16 of these patients had been infected with
Andes virus. Except for six cases, the recent
outbreak was centered in Regions X (Llanchipal)
and XI (Aysen) (combined population = 1.1
million) (Figure 2). The areas where these
patients lived are sparsely populated, with
numerous lakes, in a Nothofagus (southern
beech) forest ecosystem. From October 4, 1995, to
January 22, 1998, a total of 33 cases were
identified in Chile, with a case-fatality rate of
54%. The mean age was 31.4 years (range: 1 year
11 months to 60 years); five (15.2%) of the
patients were children under 17 years of age; and
76% of the patients were male. No cases were
reported among health-care workers.
No significant difference in mean age, case-
fatality rate, or proportion of male patients
was evident between the July to January
outbreak and previous cases; however, all the
pediatric cases occurred during the July to
January outbreak.
Family Clusters
The first family cluster (Cluster 1) of HPS
cases was reported from Cisne Medio, Lago
Verde community, Aysen region. The 39-year-old
male head of the family became ill with an acute
febrile illness on July 15 and died in transit to the
regional hospital on July 21; HPS was
subsequently confirmed by immunohistochemis-
try and RT-PCR (M and S segment), with a
genetic sequence consistent with Andes virus.
The family moved to the village of Villa
Amengual, 7 km away, on July 22 and remained
there except for a brief visit to Cisne Medio on
July 27 to retrieve personal belongings. The wife
of the index patient became ill with HPS on
August 2 and died on August 8. Her 2-year-old
and 12-year-old sons became ill 1 week and 16
days, respectively, after she became ill. HPS was
confirmed in both children by serologic testing;
both children survived. The brother-in-law of the
index patient, who continued to reside intermit-
tently in the original household, became ill 33 days
after his sister became ill and died (Figure 3). Thus,
the immediate family members became ill 12, 19,
and 28 days after leaving the family homestead,
and the intervals between the onset of the index
and later cases were 18, 25, and 34 days.
In contrast, the second family cluster
(Cluster 2) included all four members of a
household in Lago Atravesado, Coyhaique
community, Aysen region, who became ill within
5 days of each other; one of them, a 2-year-old
child with no respiratory symptoms, was
classified as having a mild hantaviral infection.
The third family cluster (Cluster 3) included a
husband, who worked in a rural area, and his
wife, who remained in the family home in urban
Coyhaique, a city of 60,000 inhabitants. The
husband became ill with symptoms suggestive of
HPS 12 days after returning to his family home.
He was hospitalized and died on December 19.
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Figure 2. Geographic distribution of hantavirus
pulmonary syndrome cases, Chile, 1995-1998.
Figure 3. Time-line listing for hantavirus pulmonary
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His wife became ill 22 days after the onset of the
husbands symptoms. She had not traveled
outside the town of Coyhaique during the
previous 12 months and reported no exposure to
rodents or their excreta. The only known
exposures for the wife were washing her
husbands clothing and caring for him while he
was ill. She survived and was discharged from
the hospital on January 28.
Genetic sequencing of viral RNA from cases
of immediate family members from Clusters 1
and 2 demonstrated 3.6% divergence in a 167-
nucleotide G2 fragment between the clusters.
However, the genetic sequence was identical
within each of the two clusters. Genetic
sequencing of viral RNA from an additional
patient from Cisne Medio not related to the
family members in Cluster 1, and the brother-in-
law in Cluster 1, demonstrated a distinct G2
sequence, with 1%-4% sequence divergence
between them (P. Padula, unpub. data).
Clinical and Histopathologic Features
In general, the clinical description of HPS
cases in Aysen was similar to that of the cases in
North America. However, included in the Aysen
cases were three children with petechiae; one of
them died rapidly with hemorrhagic pulmonary
secretions and bleeding from puncture sites. Six
of the seven patients on whom urinanalysis was
performed had microscopic hematuria and casts;
three had proteinuria of >100 mg/dl. In addition,
one child in the Llanchipal region had
concurrent acute rubella infection. One of the
most recent cases occurred in Maule, Region VII,
in a 23-week pregnant woman who had typical
HPS symptoms and fetal death. Subsequently,
disseminated intravascular coagulopathy devel-
oped and the woman died of multisystem failure.
The histopathologic features in the lung of
HPS case-patients included an interstitial
mononuclear infiltrate and intraalveolar edema.
Immunohistochemical staining showed
hantaviral antigens in the microvascular
endothelial cells of the lung and other tissues
typical SNV-associated HPS cases. Prominent
immunostaining of pulmonary macrophages was
also noted in some cases. A unique feature in the
series was fine granular immunostaining in the
hepatic cells in some cases, a pattern not
observed in a large series of North American
HPS cases previously examined (Figure 4) (12).
Laboratory Test Results
Serologic testing was conducted for all
patients and contacts of patients with confirmed
HPS cases in Aysen. Among 53 contacts of 14
patients, two (3.8%) had serologic evidence of an
acute infection (one had no illness, and another
[described previously in cluster 2] had a mild
febrile illness without pulmonary disease that
did not meet the HPS case definition), and one
was IgG positive. In addition, two hospitalized
patients had mild hantaviral disease (M. Tapia,
unpub. data). Test results of specimens (SNV and
Andes antigens were used) were 100% concor-
dant. Nested and heminested RT-PCR assays
were conducted for 20 (71.4%) of 28 HPS cases;
all 20 were positive. Sixteen (57.1%) were
sequenced and characterized as Andes virus.
Ecologic Studies
A total of 253 rodents were captured during 3
nights of trapping (574 trap nights) in the
vicinity of Coyhaique. Overall trap success
(captures per 100 trap nights) at case and control
home sites was 37% at Cisne Medio and 50% at
Lago Atravesado. Trap success at Cisne Medio
within and adjacent to the case-household was
66%, compared with only 18% at control homes;
this difference may reflect the use of rodenticides
in and around the control households. Trap
success at distances greater than 100 m from the
households was more similar between case and
controls (63% versus 43%). The most frequently
captured rodent species was O. longicaudatus,
which comprised 47% of the captured rodents in
the area; 13 (12.7%) of 102 tested were
hantavirus-antibodypositive.  Akodon olivaceus
comprised a further 33% of the captures (6 [7.5%]
of 80 were antibody-positive), and 16% were
Akodon longipilis (1 [2.7%] of 36 antibody-
positive). Eight of 10 rodents captured inside the
case-home at Cisne Medio were O. longicaudatus,
and one was hantavirus-antibodypositive. High
trap success in a forested area near Lago
Atravesado (22 captures in 40 trap nights, or 55%)
indicated that high rodent population densities
were not restricted to peridomestic areas.
Trap success was moderate near Valdivia (52
captures from 660 trap nights, or 8% trap
success) and very low near Santiago (8 captures
from 453 trap nights, or <2%). The species
composition was also very different from that
encountered in the Coyhaique area: despite691 Vol. 4, No. 4, OctoberDecember 1998 Emerging Infectious Diseases
Dispatches
trapping in rural areas, 31% of rodents captured
near Valdivia and Santiago were the murine
species, Rattus rattus, R. norvegicus, and Mus
musculus. No hantavirus-antibodypositive ro-
dents were found from Valdivia or Santiago.
Conclusions
This outbreak of HPS and the presence of
endemic disease in Chile support the assumption
that HPS will continue to occur throughout the
Americas (range of the sigmodontine rodents
that host the genetic group of HPS-causing
hantaviruses). In Latin America, endemic HPS
and epidemics have been reported in Argentina,
Brazil, and Paraguay (15-19). Sporadic cases and
SNV-like viral sequences have been reported in
these countries and in Bolivia and Uruguay (P.
Padula, pers. comm.,7,20). Retrospective studies
have verified that HPS cases occurred in the
United States as early as 1959 (21). The factors
responsible for the outbreaks in the Americas
have not been well defined and may not be the
same in all regions. However, periodic climatic
and ecologic events cause dramatic local increases
in rodent reservoir populations, known as
irruptions or ratadas (22) and may lead to an
increase in the number of rodent-human contacts.
Small-mammal trap success in the Coyhaique
area was 5 to 30 times higher than in rural areas
700 km to 1,400 km further north. These
extremely high trap success values indicate a
rodent irruption in southern Chile whose causes
may be related to the flowering of a species of
bamboo and a relatively benign preceding winter
(22). Regardless of causes, however, the
extremely high rodent densities and evidence of
hantavirus infection in the two most common
species strongly implicate contact with rodents
as the primary mode of disease transmission to
humans. The rodent species with the highest
Figure 4. A) Low-power photomicrograph of lung showing interstitial pneumonitis and intraalveolar
edema. B) Andes virus antigenpositive intraalveolar macrophages. C) Fine granular immunostaining of
hantaviral antigens in endothelial cells of pulmonary microvasculature. (A, Hematoxylin and eosin; B,C,
napthol-fast red with hematoxylin counterstain; original magnifications A x 50, B and C x 250.)692 Emerging Infectious Diseases Vol. 4, No. 4, OctoberDecember 1998
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antibody prevalence, O. longicaudatus, is the
reservoir for Andes virus in Argentina and Chile
(8,23). No hantavirus has been associated with A.
olivaceus. RT-PCR conducted on tissue samples
from seropositive animals yielded amplifiable
viral RNA from seven of seven O. longicaudatus,
two of four A. olivaceus, and one of one A.
longipilis. Sequencing showed that all PCR
products represented Andes virus, and se-
quences were nearly identical among all three
species (S. Morzunov, unpub. data). The near
identity between sequences from all three
species and the fact that two of four samples from
A. olivaceus were PCR negative suggest that
hantavirus infection in A. olivaceus and A.
longipilis represents spillover of virus from
the primary reservoir, O. longicaudatus. The
absence of viral RNA in two of the four samples
from  A. olivaceus also suggests that the
infection is of shorter duration in this
presumably nonhost species.
A number of features may eventually
differentiate HPS caused by Andes virus from
that caused by other New World viruses. Several
mild and asymptomatic hantavirus infections
have been reported in Argentina and Chile,
whereas in North America the case-to-infection
ratio is approximately 1:1 (24,25). In this
investigation, four (11%) of the patients with
serologic evidence of acute infection did not have
HPS. More mild and asymptomatic disease in some
South American hantavirus infections, in addition
to infection with nonpathogenic hantaviruses, may
be among the factors explaining antibody
prevalence as high as 40% among indigenous
persons of Argentina (C. Johnson, unpub. data).
Similar case-to-infection ratios may explain the
high prevalence (35% to 57%) of hantavirus
antibodies in some regions of Paraguay (16,26).
Disease in Chile has also been characterized
by an increased propensity toward bleeding,
with petechiae in 50% of the pediatric cases and
increased renal involvement with microscopic
hematuria and cellular casts in the three
patients whose urinanalysis results were
available. Flushing of the head and upper thorax
is indicative of vascular dysregulation and is a
well-described sign in hemorrhagic fever with
renal syndrome. It has also been described in
Andes virus-infected patients from the adjacent
areas of Argentina (17,27), but not in Chile.
The relatively large proportion of children
with HPS reported in Chile is unexplained.
Infection in children is relatively rare in the
United States, where only 8 (4.5%) of 179
reported cases were in children 16 years old or
younger. Moreover, this dearth of pediatric cases
has also been reported for hemorrhagic fever
with renal syndrome (28). It is unclear if this
greater incidence of pediatric cases is Andes
virus- or outbreak-specific. However, Argentina
has also seen a larger proportion of pediatric
HPS cases than the United States, caused by
three different genotypes: Andes, Oran, and
Lechiguanas.
Immunostaining showed hantaviral anti-
gens in the microvascular endothelial cells of the
lung and other tissues with prominent staining
of pulmonary macrophages in some cases. A
unique feature not previously described in SNV-
associated HPS cases was fine, granular
immunostaining in the hepatic cells of three
patients. The specificity of this hepatic staining
is being investigated. In Argentina, person-to-
person transmission has been demonstrated in
at least one epidemic of Andes virus infection
(17). Although the mechanism of that transmis-
sion is unknown, the increased staining of
intraalveolar pulmonary macrophages suggests
the presence of virus within the alveolar space
with the potential for small-particle aerosoliza-
tion. A comparison of disease variants that may
be hantavirus-strainspecific will be required to
address this hypothesis.
No discrepancies were observed in serologic
results from testing with SNV or Andes antigens,
which underlines the current recommendation
that diagnosis be based on serologic testing,
especially given the difficulties in handling and
transporting fresh tissues for RT-PCR and the
possibility of cross-contamination. Formalin-
fixed tissues from case-patients who died should
be used for immunohistochemical tests, particu-
larly if no serum or blood was obtained. However,
even in fatal cases, an attempt should be made to
obtain heart blood for serologic tests.
Person-to-person transmission cannot be
excluded in the first or third family cluster. We
did not trap rodents within the town limits at
Villa Amengual or in the city of Coyhaique.
However, although large numbers of rodents
were seen in rural areas, rodent infestation in
Villa Amengual or Coyhaique had not been
reported. Further, since O. longicaudatus is a
sylvatic species not generally associated with
urban habitats, subsequent exposure to infected693 Vol. 4, No. 4, OctoberDecember 1998 Emerging Infectious Diseases
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O. longicaudatus was likely not responsible for
the wifes illness in family cluster 3. However, as
in Cluster 2, Andes and other associated
hantaviruses can cause clustering attribut-
able to a single pointsource contact with
infected rodents.
Person-to-person transmission of Andes
virus-associated HPS has been documented
(17,29), although this type of transmission has not
been observed with SNV-associated HPS (24,30).
The lack of cases among health-care workers
suggests that current protective methods are
adequate; however, standard precautions should
be reinforced. Until the propensity of Andes
virus to be transmitted from person to person is
clarified, patients with suspect cases should be
isolated in separate rooms, contact and droplet
precautions should be used, and respiratory
precautions should be considered.
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